Literature DB >> 9620386

Sensitivities and specificities of premier E. coli O157 and premier EHEC enzyme immunoassays for diagnosis of infection with verotxin (Shiga-like toxin)-producing Escherichia coli. The SYNSORB Pk Study investigators.

A M Mackenzie1, P Lebel, E Orrbine, P C Rowe, L Hyde, F Chan, W Johnson, P N McLaine.   

Abstract

This study describes the performance of two rapid enzyme immunoassays, Premier E. coli O157 and Premier EHEC (Meridian Diagnostics Inc., Cincinnati, Ohio) for the detection in stools of Escherichia coli O157 and verotoxins (Shiga-like toxins), respectively. Both tests were performed on stools from 876 children presenting to eight emergency departments with diarrhea. Standard culture, including E. coli O157:H7 isolation, was performed, and paired sera were taken for anti-O157-lipopolysaccharide antibody determination. Stools from patients enrolled in the study, and those yielding discordant results, were sent to a reference laboratory for repeat testing and further investigation, including cytotoxicity and non-O157 verotoxin-producing E. coli culture. Results were classified as field results (obtained in the eight site laboratories) and resolved results (obtained after repeat testing in the central laboratory). The "gold standard" for sensitivity of both tests and for specificity of Premier E. coli O157 was isolation of E. coli O157:H7 or a fourfold anti-O157 antibody rise. Specimens positive by the Premier EHEC test and negative for E. coli O157 culture were examined for non-O157 verotoxin-producing E. coli. The field sensitivity of Premier E. coli O157 was 86%, that of Premier EHEC was 89%, and the specificity of Premier E. coli O157 was 98%. Ten of 13 discordant Premier E. coli O157 results were reassigned as true results after repeat testing. Ten non-O157 verotoxin-producing E. coli isolates were recovered from Premier EHEC-positive, E. coli O157 culture-negative stools. Only one specimen gave an unequivocally false-positive Premier EHEC result. Both tests are highly sensitive and are specific if correctly performed. The Premier EHEC test will be particularly valuable as a practical routine test for the detection of non-O157 verotoxin-producing E. coli.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620386      PMCID: PMC104886     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types.

Authors:  H A Rotbart; A Ahmed; S Hickey; R Dagan; G H McCracken; R J Whitley; J F Modlin; M Cascino; J F O'Connell; M A Menegus; D Blum
Journal:  Pediatr Infect Dis J       Date:  1997-04       Impact factor: 2.129

2.  Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome.

Authors:  M Bitzan; H Karch
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

Review 3.  Consensus conference statement: Escherichia coli O157:H7 infections--an emerging national health crisis, July 11-13, 1994.

Authors: 
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

4.  Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.

Authors:  T G Obrig; P J Del Vecchio; J E Brown; T P Moran; B M Rowland; T K Judge; S W Rothman
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

5.  Isolation of Shiga-like toxin producing Escherichia coli (O157 and non-O157) in a community hospital.

Authors:  C H Park; K M Gates; N M Vandel; D L Hixon
Journal:  Diagn Microbiol Infect Dis       Date:  1996-10       Impact factor: 2.803

6.  Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction.

Authors:  D R Pollard; W M Johnson; H Lior; S D Tyler; K R Rozee
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

7.  High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome.

Authors:  M Bitzan; E Moebius; K Ludwig; D E Müller-Wiefel; J Heesemann; H Karch
Journal:  J Pediatr       Date:  1991-09       Impact factor: 4.406

8.  Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Microvasc Res       Date:  1994-05       Impact factor: 3.514

9.  Enterobacter cloacae producing a Shiga-like toxin II-related cytotoxin associated with a case of hemolytic-uremic syndrome.

Authors:  A W Paton; J C Paton
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

10.  Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome.

Authors:  H Chart; S M Scotland; B Rowe
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

View more
  15 in total

1.  Role of the laboratory in the diagnosis of enterohemorrhagic Escherichia coli infections.

Authors:  Sue C Kehl
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 2.  Salmonella, Shigella, and yersinia.

Authors:  John P Dekker; Karen M Frank
Journal:  Clin Lab Med       Date:  2015-04-02       Impact factor: 1.935

3.  4-Aminopyrazolo[3,4-d]pyrimidine (4-APP) as a novel inhibitor of the RNA and DNA depurination induced by Shiga toxin 1.

Authors:  M Brigotti; D Carnicelli; P Accorsi; S Rizzi; L Montanaro; S Sperti
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

4.  Shiga toxin-producing Escherichia coli in children: diagnosis and clinical manifestations of O157:H7 and non-O157:H7 infection.

Authors:  Christina R Hermos; Marcie Janineh; Linda L Han; Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

5.  Performance of the ImmunoCard STAT! E. coli O157:H7 test for detection of Escherichia coli O157:H7 in stools.

Authors:  A Mackenzie; E Orrbine; L Hyde; M Benoit; F Chan; C Park; J Alverson; A Lembke; D Hoban; W Kennedy
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

6.  Solid-phase capture of proteins, spores, and bacteria.

Authors:  B C Weimer; M K Walsh; C Beer; R Koka; X Wang
Journal:  Appl Environ Microbiol       Date:  2001-03       Impact factor: 4.792

7.  Occurrence of potentially human-pathogenic Escherichia coli O103 in Norwegian sheep.

Authors:  Camilla Sekse; Marianne Sunde; Petter Hopp; Torkjel Bruheim; Kofitsyo Sewornu Cudjoe; Bjørg Kvitle; Anne Margrete Urdahl
Journal:  Appl Environ Microbiol       Date:  2013-09-27       Impact factor: 4.792

8.  Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo, Spain, from 1992 through 1999.

Authors:  J E Blanco; M Blanco; M P Alonso; A Mora; G Dahbi; M A Coira; J Blanco
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

9.  Application of multiplex PCR for detection of non-O157 verocytotoxin-producing Escherichia coli in bloody stools: identification of serogroups O26 and O111.

Authors:  M Louie; S Read; A E Simor; J Holland; L Louie; K Ziebell; J Brunton; J Hii
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

10.  The highly virulent 2006 Norwegian EHEC O103:H25 outbreak strain is related to the 2011 German O104:H4 outbreak strain.

Authors:  Trine M L'Abée-Lund; Hannah J Jørgensen; Kristin O'Sullivan; Jon Bohlin; Goro Ligård; Per Einar Granum; Toril Lindbäck
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.